The RORα agonist SR1078 recently was shown to be well tolerated and efficacious in an animal model of autism (38) and our present study indicates that this agonist is active in normoxic and hypoxic cardiomyocytes (Fig. 2, E and G). The gene discussed is RORA; the disease is autism.